Is cancer related to hypertension or to its treatment?

Clinical and Experimental Hypertension

Volumn 21, Issue 5-6, 1999, Pages 937-946

  Lever, A F ^a   Hole, D J ^b   Gillis, C R ^b   McInnes, G T ^a   Meredith, P A ^a   Murray, L S ^a   Reid, J L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b W of Scotland Cancer Survlnc Unit   (United Kingdom)

Author keywords

ACE inhibitors; Antihypertensive drugs; Beta blockers; Blood pressure; Calcium channel blockers; Cancer; Diuretics

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANIMAL EXPERIMENT; CANCER; CANCER RISK; CONFERENCE PAPER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NONHUMAN; RAT; RISK ASSESSMENT; SODIUM INTAKE; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0032769665     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909061022     Document Type: Conference Paper

References (20)

1. Hamet P: Cancer and hypertension: an unresolved issue. Hypertension 1996; 28:321-324.
2. M.R.C Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. B.M.J. 1992; 304:405-412.
3. Olsen J.H. Commentary: Interpretation in drug epidemiology. Lancet 1998; 352:162-163.
4. Isles C.G., Walker L.M., Beevers D.G. et al: Mortality in patients of the Glasgow Blood Pressure Clinic. J. Hypertension 1986; 4:141-156.
5. Hole D.J., Gillis C.R., McCallum I.R. et al: Cancer risk of hypertensive patients taking calcium antagonists. J Hypertension 1998; 16:119-124.
6. Joussens J.V., Geboers J: Nutrition and gastric cancer. Proc. Nutr. Soc. 1981: 40:37-46
7. Dyer A. R., Berkson D.M., Stamler J. et al: High blood pressure: a risk factor for cancer mortality? Lancet 1975; I:1051-1056.
8. Khaw K-T., Barrett-Connor E: Systolic blood pressure and cancer mortality in an elderly population. Amer. J. Epidemiol. 1984: 120:550-558.
9. Goldbourt U, Holtzman E., Yaari S. et al: Elevated systolic blood pressure as a predictor of long-term cancer mortality: analysis by site and histologic subtype in 10,000 middle-aged and elderly men. J.N.C.L. 1986; 77:63-70.
10. Wannamethee G, Shaper A.G: Blood pressure and cancer in middle-aged British men. Int. J. Epidemiol. 1996; 25:22-31.
11. Lindop G.B.M., Leckie B.J., Mimran A: Renin-secreting tumours. In: The renin-angiotensin-system (Robertson JIS, Nicholls GM eds) , London: Gower Medical Publishing 1993:54.
12. Hole D.J., Hawthorne B.M., Isles C.G. et al: Incidence of and mortality from cancer in hypertensive patients. B.M.J. 1993; 306:609-611.
13. Lever A.F., Hole D.J., Gillis C.R. et al: Do inhibitors of angiotensin I converting enzyme protect against risk of cancer? Lancet 1998; 352:179-184.
14. Pahor M, Guralnik J. M., Salive M.E. et al: Do calcium channel blockers increase the risk of cancer? Amer. J. Hypertension 1996; 9:695-699.
15. Pahor M, Guralnik J.M., Ferrucci L. et al: Calcium channel blockers and incidence of cancer in aged populations. Lancet 1996; 348:493-497.
16. Jick H, Jick S, Derby LE. et al: Calcium channel blockers and risk of cancer. Lancet 1997; 349:525-528.
17. Olsen J.H., Sorensen H.T., Friis S. et al: Cancer risk in users of calcium channel blockers. Hypertension 1997; 29:1091-1094.
18. Rosenberg L., Rao R.S., Palmer J.R. et al: Calcium channel blockers and the risk of cancer. J.A.M.A. 1998; 279:1000-1004.
19. Volpert O.V., Ward W.F., Lingen M.W. et al: Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J. Clin. Invest. 1996; 98:671-679.
20. Hii S-I, Nicol D.L., Gotley D.C. et al: Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma. Brit. J. Cancer 1998; 77:880-883.